2
Clinical Trials associated with TRF-1101A randomised, double-blind, placebo-controlled study to assess the safety and activity of TRF-1101 on microvascular blood flow, vascular endothelial injury, and vasoocclusive pain in patients with sickle cell disease - A Study of TRF-1101 in Sickle Cell Disease
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Activity of TRF-1101 on Microvascular Blood Flow, Vascular Endothelial Injury, and Vasoocclusive Pain in Patients With Sickle Cell Disease
This study is designed to assess the safety, tolerability, and activity of TRF-1101 on microvascular blood flow, vascular endothelial injury, and vasoocclusive pain associated with sickle cell disease.
100 Clinical Results associated with TRF-1101
100 Translational Medicine associated with TRF-1101
100 Patents (Medical) associated with TRF-1101
100 Deals associated with TRF-1101